AstraZeneca Pharma India to launch cancer drug

Acalabrutinib 100 mg capsules are used for treatment of various types of blood cancers

AstraZeneca Pharma India to launch cancer drug

Photo for representational purpose only.

New Delhi, October 15

Drug firm AstraZeneca Pharma India on Thursday said it would launch its Acalabrutinib 100 mg capsules, used for treatment of various types of blood cancers, under the brand name 'Calquence' in the country on October 21.

The capsules are indicated for treatment of patients with mantle cell lymphoma (MCL) who have received at least one prior therapy and for treatment of patients with chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL), AstraZeneca Pharma India said in a filing to the BSE.

Shares of AstraZeneca Pharma India Ltd on Thursday closed 0.61 per cent lower at Rs 4,266.65 apiece on the BSE. PTI

Top Stories

Pak minister admits to Imran Khan govt’s role in Pulwama terrorist attack

Pak minister admits to Imran Khan govt’s role in Pulwama terrorist attack

‘You and us are all part of that success’, Fawad Chaudhry te...

Train service in Punjab not to resume as BKU refuses to lift blockade

Train service in Punjab not to resume as BKU refuses to lift blockade

An emergency meeting was called by the three-member committe...

Stubble-burning: President promulgates ordinance to deal with air pollution in Delhi-NCR

Stubble-burning: President promulgates ordinance to deal with air pollution in Delhi-NCR

Ordinance sets up Commission on Air Quality Management in De...

3 dead as woman beheaded in knife attack at French church

3 dead as woman beheaded in knife attack at French church

Attacker shouts ‘Allahu Akbar’; incident described as terror...

Cities

View All